NCT02708160

Brief Summary

This is a double blind, cross-over, controlled clinical trial utilizing thirty (30) adults to evaluate remineralization of early caries lesions.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2016

Shorter than P25 for phase_2

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 15, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

February 21, 2019

Status Verified

February 1, 2019

Enrollment Period

3 months

First QC Date

March 4, 2016

Last Update Submit

February 19, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mineral Change (delta Z)

    Tooth samples of human enamel are placed in a retainer and worn by each study subject. Enamel block samples will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions, vol % µm) before being placed in the retainer. These baseline values will be compared with the post use delta mineral change ( ΔZ).

    Baseline

  • Mineral Change (delta Z)

    Tooth samples of human enamel are placed in a retainer and worn by each study subject. After 2 weeks of brushing while wearing the study oral retainer, samples from the retainer will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions, vol % µm). These post use values will be compared to the baseline values to give a delta mineral change ( ΔZ).

    2 weeks (from Baseline)

Study Arms (3)

Fluoride Free toothpaste

PLACEBO COMPARATOR

Fluoride free (0%), silica based toothpaste

Drug: Fluoride Free toothpasteDrug: 1.1% Fluoride toothpasteDrug: 0.243% Fluoride toothpaste

1.1% Fluoride toothpaste

EXPERIMENTAL

Prevident 5000 Plus, silica based toothpaste

Drug: Fluoride Free toothpasteDrug: 1.1% Fluoride toothpasteDrug: 0.243% Fluoride toothpaste

0.243% Fluoride Toothpaste

ACTIVE COMPARATOR

silica based fluoride toothpaste

Drug: Fluoride Free toothpasteDrug: 1.1% Fluoride toothpasteDrug: 0.243% Fluoride toothpaste

Interventions

Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.

Also known as: Control toothpaste containing no anti-cavity ingredients
0.243% Fluoride Toothpaste1.1% Fluoride toothpasteFluoride Free toothpaste

Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.

Also known as: Prevident 5000 Plus
0.243% Fluoride Toothpaste1.1% Fluoride toothpasteFluoride Free toothpaste

Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait 1 minute before rinsing with water.

Also known as: silica based fluoride toothpaste
0.243% Fluoride Toothpaste1.1% Fluoride toothpasteFluoride Free toothpaste

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and/or female subjects 18 to 50 years inclusive
  • Minimum of 20 natural uncrowned teeth (excluding third molars) must be present
  • Willing to wear retainer 24 hours per day
  • No active, unrestored cavities
  • Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥ 0.2 ml/min respectively) ascertained from a preliminary sialometry
  • Available throughout entire study
  • Willing to use only assigned products for oral hygiene throughout the duration of the study
  • Must give written informed consent
  • Must be in good general health
  • No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study

You may not qualify if:

  • Advanced periodontal disease
  • Medical condition which requires premedication prior to dental visits/procedures
  • Not enough teeth to secure the oral retainer
  • Diseases of the soft or hard oral tissues
  • Wear an Orthodontic retainer(s)
  • Impaired salivary function
  • Current use drugs that can affect salivary flow
  • Use antibiotics one (1) month prior to or during this study
  • Positive urine test for pregnancy (a urine pregnancy test will be performed on female subjects of child-bearing potential)
  • Participate in another clinical study one (1) week prior to the start of the washout period or during this 9-week study period
  • Use tobacco products
  • Allergic history to common toothpaste ingredients
  • Immune compromised individuals (HIV, AIDS, immuno-suppressive drug therapy) as determined by review of medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dental Caries

Interventions

Tin Fluorides

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsTin CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Bennet Amaechi, PhD, DDS

    University of Texas

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2016

First Posted

March 15, 2016

Study Start

March 1, 2016

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

February 21, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share